Passage Bio Inc.

NASDAQ: PASG
Share price (12/20/24): $0.66
Market cap (12/20/24): $40.8 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement

Registration of securities for employees

Shelf registration

Registration of securities for employees

Updated info for already-effective prospectus

Ownership Filter

Orbimed Advisors LLC, OrbiMed Capital GP VII LLC

Orbimed Advisors LLC, OrbiMed Capital GP VII LLC

Orbimed Advisors LLC

Orbimed Capital LLC

Nichols Weston, Lynx1 Capital Management LP

News Filter

Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights

Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Conference

To Present Positive Interim Data From Cohort 1 Patients With FTD-GRN in upliFT-D Study at 14th International Conference on Frontotemporal Dementias

Change in Directors, Officers or Compensation

Material Impairments

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission

Letter from the SEC

Scanned paper annual report submission